New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis

ConclusionSimvastatin combined regimens have promising synergistic effects on bone microarchitecture with cardiovascular protective effects which might be considered by clinicians as valid preventive and therapeutic strategy in patients with osteoporosis with or highly susceptible to cardiovascular disease.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research